Literature DB >> 17139434

Synchronously resected double primary hepatic cancers - hepatocellular carcinoma and cholangiolocellular carcinoma.

Masanori Matsuda1, Michio Hara, Tetsuya Suzuki, Hiroshi Kono, Hideki Fujii.   

Abstract

The frequency of double primary cancers in the liver is very low. All reported cases are double cancers consisting of hepatocellular carcinoma (HCC) and intrahepatic cholangiocellular carcinoma (CCC). We herein report a surgical patient who had simultaneous double cancers consisting of HCC and cholangiolocellular carcinoma (CoCC). This is the first case report of such a patient. A 70-year-old Japanese man was admitted to our hospital for further examination of two hepatic nodules. He had a history of schistosomiasis japonica, idiopathic pulmonary fibrosis, and diabetes mellitus. Laboratory data revealed that hepatitis C virus (HCV) antibody was positive and hepatic enzymes were slightly elevated. The level of prothrombin induced by vitamin K absence or antagonist II was elevated. Computed tomography depicted two tumors; one, measuring 4.0 cm in diameter, was in the medial segment and the other, 2.2 cm in diameter, was in the posterior superior segment of the liver. The larger tumor showed contrast enhancement and the smaller one showed enhancement at the tumor periphery in the hepatic arterial phase. In the portal phase, the larger tumor became less dense than the liver parenchyma, but the periphery of the smaller one showed continuous enhancement. He underwent an operation under a diagnosis of double hepatic cancers, consisting of HCC and CCC. However, microscopic examination of the resected tumors revealed that the larger tumor was moderately differentiated HCC and the smaller one was CoCC.

Entities:  

Mesh:

Year:  2006        PMID: 17139434     DOI: 10.1007/s00534-006-1118-0

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  13 in total

1.  Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.

Authors:  Shinji Takashimizu; Sei-Ichiro Kojima; Junko Nagata; Yasuhiro Nishizaki; Tatehiro Kagawa; Koichi Shiraishi; Tetsuya Mine; Jun-Ichi Kaneko; Norihiro Kokudo; Norihito Watanabe
Journal:  Clin J Gastroenterol       Date:  2011-03-24

2.  Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Dong-Hwan Jung; Shin Hwang; Ki-Hun Kim; Seung-Mo Hong; Young-Joo Lee; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Gil-Chun Park; Eun Sil Yu; Sung-Gyu Lee
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

3.  S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

Authors:  Takashi Yamaguchi; Toshihito Seki; Ryosuke Inokuchi; Rinako Kawamura; Miki Murata; Koichi Matsuzaki; Osamu Nakashima; Tsutomu Kumabe; Kazuichi Okazaki
Journal:  Mol Clin Oncol       Date:  2016-10-11

4.  Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis.

Authors:  Takuya Watanabe; Jun Sakata; Takashi Ishikawa; Yoshio Shirai; Takeyasu Suda; Haruka Hirono; Katsuhiko Hasegawa; Kenji Soga; Koichi Shibasaki; Yukifumi Saito; Hajime Umezu
Journal:  World J Hepatol       Date:  2009-10-31

5.  A case of cholangiolocellular carcinoma asynchronously developing 3 years after the resection of hepatocellular carcinoma.

Authors:  Masaya Iwamuro; Hirofumi Kawamoto; Tsuneyoshi Ogawa; Takehiro Tanaka; Takahito Yagi; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2009-02-11

6.  Chronic schistosomiasis japonica is an independent adverse prognostic factor for survival in hepatocellular carcinoma patients who have undergone hepatic resection: clinicopathological and prognostic analysis of 198 consecutive patients.

Authors:  Masanori Matsuda; Hideki Fujii
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

7.  Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case.

Authors:  Norihiro Ishii; Hideki Suzuki; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Satoshi Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2015-06

8.  Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports.

Authors:  Kyu Sik Jung; Kyeong Hyeon Chun; Gi Hong Choi; Hyae Min Jeon; Hye Sun Shin; Young Nyun Park; Jun Yong Park
Journal:  BMC Res Notes       Date:  2013-12-07

9.  Synchronous hepatocellular carcinoma and cholangiocarcinoma in a patient transplanted for cryptogenic cirrhosis.

Authors:  B Geramizadeh; R Gity; A Bahraini; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2014

Review 10.  Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.

Authors:  Chao Wu; Dou-Sheng Bai; Guo-Qing Jiang; Sheng-Jie Jin
Journal:  World J Surg Oncol       Date:  2014-11-10       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.